Cargando…
Safety and immunogenicity of the Rift Valley fever arMP-12 ΔNSm21/384 candidate vaccine in pregnant ewes
Rift Valley fever (RVF) poses a threat to human and animal health as well as economic losses due to abortion, new-born teratogenic effect and mortality. Safe and effective vaccines are critically needed to prevent the disease in humans and livestock. The objective of this study was to assess safety...
Autores principales: | Boumart, Z., Bamouh, Z., Hamdi, J., Safini, N., Tadlaoui, K.O., Bettinger, G., Watts, D.M., Elharrak, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7415414/ https://www.ncbi.nlm.nih.gov/pubmed/32793877 http://dx.doi.org/10.1016/j.jvacx.2020.100070 |
Ejemplares similares
-
Comparative thermo-stability of two Rift Valley fever virus vaccine candidate CL13T with a recombinant arMP-12ΔNSm21/384
por: Daouam, S, et al.
Publicado: (2020) -
Safety and immunogenicity of Rift Valley fever MP-12 and arMP-12ΔNSm21/384 vaccine candidates in goats (Capra aegagrus hircus) from Tanzania
por: Nyundo, Salama, et al.
Publicado: (2019) -
In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Lumpy Skin disease viruses
por: Safini, N., et al.
Publicado: (2021) -
Peste des petits ruminants pathogenesis on experimental infected goats by the Moroccan 2015 isolate
por: Bamouh, Z., et al.
Publicado: (2019) -
Production of small ruminant morbillivirus, rift valley fever virus and lumpy skin disease virus in CelCradle™ -500A bioreactors
por: Rhazi, Halima, et al.
Publicado: (2021)